- ¥614bn
- ¥618bn
- ¥163bn
- 86
- 24
- 100
- 84
Annual balance sheet for Organo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 12,804 | 20,198 | 15,558 | 17,642 | 16,751 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 51,076 | 54,782 | 75,664 | 82,201 | 83,857 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 89,702 | 102,862 | 136,765 | 153,469 | 164,367 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 18,974 | 20,995 | 20,795 | 20,634 | 21,516 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 115,011 | 130,506 | 164,854 | 182,703 | 194,396 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 40,749 | 43,072 | 68,738 | 72,602 | 64,401 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 47,797 | 54,670 | 78,684 | 80,775 | 73,448 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 67,214 | 75,836 | 86,170 | 101,928 | 120,948 |
| Total Liabilities & Shareholders' Equity | 115,011 | 130,506 | 164,854 | 182,703 | 194,396 |
| Total Common Shares Outstanding |